Robot with sense of touch to allow surgeons to operate remotely


During keyhole surgery, surgeons typically rely on sight as they remotely control the delicate operation. A new robot promises to give them one important extra sense: touch. The invention, revealed Wednesday at the Australasian Simulation Congress in Melbourne, Australia, is called the HeroSurg. Created by a team at Australia's Deakin University, as well as Harvard University, the robot may look a little terrifying but its inventors hope it will make operations safer and more accurate. Unlike most current keyhole surgery tools, the robot uses haptic feedback to deliver a sense of touch to the operator, as well as 3D images so the surgeon can see where their instruments are placed.

Samsung partners with Deakin University for healthcare IoT exploration


Samsung Australia has partnered with Deakin University and independent research group Unisono to develop Internet of Things (IoT)-based smart home technology and software in a bid to overcome healthcare challenges. The partnership will see the trial of three smart home technology-focused projects designed to guide Australian research and development programs that will explore how IoT technology and applied learning-based systems of artificial intelligence can support assisted living programs in healthcare. Ian Aitken, CTO and head of New Business Development at Samsung Australia, told ZDNet he believes IoT and the concept of a smart home has not progressed much further than sensors opening a garage or switching lights on or off. He said the partnership with Deakin and Unisono will instead focus on improving things for people at home and will also aim to speed up the availability and deployment of such technology for people who need it. "We really want to put the smarts into smart homes.

Is Robotic Prostate Surgery Better Than Traditional Surgery? WSJD - Technology

Advocates of robotically assisted prostatectomy argue that the procedure brings a number of advantages. Among them: less blood loss, shorter stays in the hospital and faster recovery times. However, it isn't clear that the robotically assisted procedures provide an advantage when it comes to survival rates and urinary and erection problems. And it costs significantly more. Ashutosh Tewari, system chairman of the department of urology at Mount Sinai Health System in New York City, believes the robotic surgery is better.

Brain surgery: The robot efficacy test?


The internet hummed last week with reports that "Humans Still Make Better Surgeons Than Robots." Stanford University Medical Center set off the tweetstorm with its seemingly scathing report on robotic surgery. When reading the research of 24,000 patients with kidney cancer, I concluded that the problem lied with the humans overcharging patients versus any technology flaw. In fact, the study praised robotic surgery for complicated procedures and suggested the fault lied with hospitals unnecessarily pushing robotic surgery for simple operations over conventional methods, which led to "increases in operating times and cost." Dr. Benjamin Chung, the author of the report, stated that the expenses were due to either "the time needed for robotic operating room setup" or the surgeon's "learning curve" with the new technology.

Welsh hospital uses da Vinci machine to perform 350 operations in 18 months

Daily Mail - Science & tech

Prostate cancer is the most common cancer in men in the UK, with more than 40,000 new cases diagnosed every year. But help in beating this form of life-threatening disease is coming in an usual form - from robots. A revolutionary form of surgery that uses a state-of-the-art robot to remove tumours has treated more than 350 patients in its first 18 months in a hospital in Wales. A revolutionary form of surgery which uses a state-of-the-art robot to remove tumours has treated more than 350 patients in its first 18 months in a hospital in Wales. Named the da Vinci robot, the equipment is being used three days a week in the University Hospital of Wales, and solely on prostate cancer patients.